Cargando…

Comorbidity as a predictor of racial and ethnic disparities in cancer in the United States population

AIMS: This study aims to examine the racial and ethnic disparity in cancer prevalence and determine if comorbidities can explain this disparity. STUDY DESIGN: This was a cross-sectional study. METHODS: The study examined cancer prevalence among adults who self-identified as White, Black, and Other r...

Descripción completa

Detalles Bibliográficos
Autores principales: Akonde, Maxwell, Gupta, Rajat Das, Dakurah, Ottovon Bismark, Hartsell, Reston
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9461574/
https://www.ncbi.nlm.nih.gov/pubmed/36101574
http://dx.doi.org/10.1016/j.puhip.2021.100175
_version_ 1784786993954160640
author Akonde, Maxwell
Gupta, Rajat Das
Dakurah, Ottovon Bismark
Hartsell, Reston
author_facet Akonde, Maxwell
Gupta, Rajat Das
Dakurah, Ottovon Bismark
Hartsell, Reston
author_sort Akonde, Maxwell
collection PubMed
description AIMS: This study aims to examine the racial and ethnic disparity in cancer prevalence and determine if comorbidities can explain this disparity. STUDY DESIGN: This was a cross-sectional study. METHODS: The study examined cancer prevalence among adults who self-identified as White, Black, and Other races in the US population according to data from the 2017 National Health Interview Survey. RESULTS: Cancer was 58.5% [OR = 0.415; 95% CI: 0.346–0.498] and 57.5% [OR = 0.425; 95%CI: 0.346–0.522] more likely to be found in the White compared to the Black adults and White compared to Other race adults, respectively. After adjusting for the comorbidities, the odds of cancer in White adults increased marginally compared to Black adults [OR = 0.407; 95%CI: 0.338–0.490] and decreased marginally compared to Other race adults [OR = 0.462; 95%CI: 0.374–0.569] even though the odds remained significant. Ever smoking, age of 50 years or more, Former and current alcohol consumption, overweight and obesity, being female and physical inactivity were found to be significantly associated with higher odds of cancer. CONCLUSIONS: This study did identify a racial and ethnic disparity in cancer prevalence between White and Black adults and White and Other adult races. However, this racial and ethnic disparity could not be explained by comorbidities.
format Online
Article
Text
id pubmed-9461574
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-94615742022-09-12 Comorbidity as a predictor of racial and ethnic disparities in cancer in the United States population Akonde, Maxwell Gupta, Rajat Das Dakurah, Ottovon Bismark Hartsell, Reston Public Health Pract (Oxf) Original Research AIMS: This study aims to examine the racial and ethnic disparity in cancer prevalence and determine if comorbidities can explain this disparity. STUDY DESIGN: This was a cross-sectional study. METHODS: The study examined cancer prevalence among adults who self-identified as White, Black, and Other races in the US population according to data from the 2017 National Health Interview Survey. RESULTS: Cancer was 58.5% [OR = 0.415; 95% CI: 0.346–0.498] and 57.5% [OR = 0.425; 95%CI: 0.346–0.522] more likely to be found in the White compared to the Black adults and White compared to Other race adults, respectively. After adjusting for the comorbidities, the odds of cancer in White adults increased marginally compared to Black adults [OR = 0.407; 95%CI: 0.338–0.490] and decreased marginally compared to Other race adults [OR = 0.462; 95%CI: 0.374–0.569] even though the odds remained significant. Ever smoking, age of 50 years or more, Former and current alcohol consumption, overweight and obesity, being female and physical inactivity were found to be significantly associated with higher odds of cancer. CONCLUSIONS: This study did identify a racial and ethnic disparity in cancer prevalence between White and Black adults and White and Other adult races. However, this racial and ethnic disparity could not be explained by comorbidities. Elsevier 2021-08-26 /pmc/articles/PMC9461574/ /pubmed/36101574 http://dx.doi.org/10.1016/j.puhip.2021.100175 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Research
Akonde, Maxwell
Gupta, Rajat Das
Dakurah, Ottovon Bismark
Hartsell, Reston
Comorbidity as a predictor of racial and ethnic disparities in cancer in the United States population
title Comorbidity as a predictor of racial and ethnic disparities in cancer in the United States population
title_full Comorbidity as a predictor of racial and ethnic disparities in cancer in the United States population
title_fullStr Comorbidity as a predictor of racial and ethnic disparities in cancer in the United States population
title_full_unstemmed Comorbidity as a predictor of racial and ethnic disparities in cancer in the United States population
title_short Comorbidity as a predictor of racial and ethnic disparities in cancer in the United States population
title_sort comorbidity as a predictor of racial and ethnic disparities in cancer in the united states population
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9461574/
https://www.ncbi.nlm.nih.gov/pubmed/36101574
http://dx.doi.org/10.1016/j.puhip.2021.100175
work_keys_str_mv AT akondemaxwell comorbidityasapredictorofracialandethnicdisparitiesincancerintheunitedstatespopulation
AT guptarajatdas comorbidityasapredictorofracialandethnicdisparitiesincancerintheunitedstatespopulation
AT dakurahottovonbismark comorbidityasapredictorofracialandethnicdisparitiesincancerintheunitedstatespopulation
AT hartsellreston comorbidityasapredictorofracialandethnicdisparitiesincancerintheunitedstatespopulation